Doseology Sciences Inc. (CSE:MOOD)

Market Cap	2.35M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	7.84M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Average Volume	2,942
Open	0.2550
Previous Close	0.3000
Day's Range	0.2550 - 0.2550
52-Week Range	0.0850 - 4.0000
Beta	-3.72
RSI	38.39
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada. The company offers medicinal mushroom products, including tinctures, powders, and herbal supplements to enhance health with a focus on mental health. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in Januar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD